These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 24024319)
1. Role of dongchongxiacao (Cordyceps) in prevention of contrast-induced nephropathy in patients with stable angina pectoris. Zhao K; Li Y; Zhang H J Tradit Chin Med; 2013 Jun; 33(3):283-6. PubMed ID: 24024319 [TBL] [Abstract][Full Text] [Related]
2. [Predict value of monitoring changes of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 after coronary angiography and percutaneous coronary intervention on early diagnosis of contrast-induced nephropathy]. Wang L; Pu X Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Apr; 42(4):301-4. PubMed ID: 24924456 [TBL] [Abstract][Full Text] [Related]
3. Effect of Dongchongxiacao (Cordyceps) therapy on contrast-induced nephropathy in patients with type 2 diabetes and renal insufficiency undergoing coronary angiography. Kai Z; Yongjian L; Sheng G; Yu L J Tradit Chin Med; 2015 Aug; 35(4):422-7. PubMed ID: 26427112 [TBL] [Abstract][Full Text] [Related]
4. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Ling W; Zhaohui N; Ben H; Leyi G; Jianping L; Huili D; Jiaqi Q Nephron Clin Pract; 2008; 108(3):c176-81. PubMed ID: 18287807 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a Diagnostic Test of Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Urine KIM-1 in Contrast-Induced Nephropathy (CIN). Liao B; Nian W; Xi A; Zheng M Med Sci Monit; 2019 Jan; 25():565-570. PubMed ID: 30659575 [TBL] [Abstract][Full Text] [Related]
6. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1? Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography. Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ Angiology; 2014 Mar; 65(3):216-23. PubMed ID: 23378196 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient. Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography. Filiopoulos V; Biblaki D; Vlassopoulos D Ren Fail; 2014 Jul; 36(6):979-86. PubMed ID: 24673459 [TBL] [Abstract][Full Text] [Related]
10. Could neutrophil-gelatinase-associated lipocalin and cystatin C predict the development of contrast-induced nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine values? Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Pawlak K; Mysliwiec M; Lawnicki S; Szmitkowski M; Dobrzycki S Kidney Blood Press Res; 2007; 30(6):408-15. PubMed ID: 17901710 [TBL] [Abstract][Full Text] [Related]
11. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease. Alharazy SM; Kong N; Saidin R; Gafor AH; Maskon O; Mohd M; Zakaria SZ Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616 [TBL] [Abstract][Full Text] [Related]
12. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL). van de Vrie M; Deegens JK; van der Vlag J; Hilbrands LB Am J Kidney Dis; 2014 Apr; 63(4):573-6. PubMed ID: 24268306 [TBL] [Abstract][Full Text] [Related]
13. Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study. Zwiers AJ; de Wildt SN; van Rosmalen J; de Rijke YB; Buijs EA; Tibboel D; Cransberg K Crit Care; 2015 Apr; 19(1):181. PubMed ID: 25895828 [TBL] [Abstract][Full Text] [Related]
14. Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication. Gil HW; Yang JO; Lee EY; Hong SY Clin Toxicol (Phila); 2009 Nov; 47(9):870-5. PubMed ID: 19827907 [TBL] [Abstract][Full Text] [Related]
16. Kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as prognostic markers in idiopathic membranous nephropathy. Maas RJ; van den Brand JA; Waanders F; Meijer E; Goor van H; Peters HP; Hofstra JM; Wetzels JF Ann Clin Biochem; 2016 Jan; 53(Pt 1):51-7. PubMed ID: 25762211 [TBL] [Abstract][Full Text] [Related]
17. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction. Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749 [TBL] [Abstract][Full Text] [Related]
18. Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP. Parmaksız G; Noyan A; Dursun H; İnce E; Anarat R; Cengiz N Pediatr Nephrol; 2016 Jan; 31(1):97-103. PubMed ID: 26324091 [TBL] [Abstract][Full Text] [Related]
19. NGAL (neutrophil gelatinase-associated lipocalin) and cystatin C: are they good predictors of contrast nephropathy after percutaneous coronary interventions in patients with stable angina and normal serum creatinine? Bachorzewska-Gajewska H; Malyszko J; Sitniewska E; Malyszko JS; Poniatowski B; Pawlak K; Dobrzycki S Int J Cardiol; 2008 Jul; 127(2):290-1. PubMed ID: 17566573 [TBL] [Abstract][Full Text] [Related]
20. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention. Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]